Showing results (11-20 of 80) with videos related to
Sort By:
Pageof 8
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 29, 2004
Epstein-Barr Virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignanciesJulie L Ryan, Hongxin Fan, Lode J Swinnen, et al.Leukemia & Lymphoma|June 22, 2013
Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404)Kristen Ganjoo, Fangxin Hong, Sandra J Horning, et al.Transplantation|July 23, 2008
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorderLode J Swinnen, Michael LeBlanc, Thomas M Grogan, et al.Leukemia & Lymphoma|January 19, 2019
R-CHOP without radiation in frontline management of primary mediastinal B-cell lymphomaMarcus Messmer, Hua-Ling Tsai, Ravi Varadhan, et al.Journal of Neuro-Oncology|January 5, 2008
A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149)Lode J Swinnen, Cathryn Rankin, Hetty Carraway, et al.British Journal of Haematology|April 1, 2015
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)Lode J Swinnen, Hailun Li, Andrew Quon, et al.Oncotarget|February 9, 2018
Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): a trial of the ECOG-ACRIN cancer research group (E1F05)Lode J Swinnen, Anne O'Neill, Philip H Imus, et al.Oncotarget|October 14, 2015
Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usageGenevieve M Crane, Helen Powell, Rumen Kostadinov, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2024
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular LymphomaBrad S Kahl, Opeyemi A Jegede, Christopher Peterson, et al.Journal of Medical Virology|November 16, 2004
Epstein-Barr viral load as a marker of lymphoma in AIDS patientsHongxin Fan, Seong Cheol Kim, Chukwuemeka O Chima, et al.Pageof 8